Lindbrook Capital, LLC - ITEOS THERAPEUTICS INC ownership

ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 147 filers reported holding ITEOS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of ITEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,672
+162.2%
244
+216.9%
0.00%
Q2 2023$1,019
+211.6%
77
+220.8%
0.00%
Q1 2023$327
-78.0%
24
-68.4%
0.00%
Q4 2022$1,484760.00%
Q3 2022$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q2 2022$19,000
-36.7%
9300.0%0.00%
-40.0%
Q1 2022$30,000
-30.2%
9300.0%0.01%
-28.6%
Q4 2021$43,000
+65.4%
930
-7.0%
0.01%
+16.7%
Q2 2021$26,0001,0000.01%
Other shareholders
ITEOS THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 3,706,663$126,694,00024.48%
MPM BioImpact LLC 2,355,557$80,513,00010.12%
Boxer Capital, LLC 4,345,016$148,513,0005.04%
RA Capital Management 4,417,258$150,982,0002.28%
Ally Bridge Group (NY) LLC 322,794$11,033,0002.12%
Asymmetry Capital Management, L.P. 102,286$3,496,0001.81%
RTW INVESTMENTS, LP 2,762,791$94,432,0001.47%
COWEN AND COMPANY, LLC 588,238$20,106,0001.38%
Artal Group S.A. 1,094,047$37,395,0000.66%
HighVista Strategies LLC 19,804$677,0000.50%
View complete list of ITEOS THERAPEUTICS INC shareholders